Kidney Cancer Clinical Trial

Pro-active Genetic Testing in Kidney Transplant Patients

Summary

The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

- Post transplant Kidney and Kidney Pancreas recipients.

Exclusion Criteria:

Simultaneous Liver Kidney Transplant.
Simultaneous Heart Kidney Transplant.
Non renal transplant history.

Study is for people with:

Kidney Cancer

Estimated Enrollment:

200

Study ID:

NCT05298904

Recruitment Status:

Recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic Arizona
Scottsdale Arizona, 85259, United States More Info
Girish Mour, M.D
Contact
480-342-1283
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

200

Study ID:

NCT05298904

Recruitment Status:

Recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.